Global Drug Eluting Implant Market Research Report 2021

1 Drug Eluting Implant Market Overview

• 1.1 Product Overview and Scope of Drug Eluting Implant
• 1.2 Drug Eluting Implant Segment by Type
  • 1.2.1 Global Drug Eluting Implant Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Rapamycin Eluting Implant
  • 1.2.3 Paclitaxel Eluting Implant
  • 1.2.4 Everolimus Eluting Implant
  • 1.2.5 Others
• 1.3 Drug Eluting Implant Segment by Application
  • 1.3.1 Global Drug Eluting Implant Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Ambulatory Surgical Centers
  • 1.3.5 Others
• 1.4 Global Drug Eluting Implant Market Size Estimates and Forecasts
  • 1.4.1 Global Drug Eluting Implant Revenue 2016-2027
  • 1.4.2 Global Drug Eluting Implant Sales 2016-2027
  • 1.4.3 Drug Eluting Implant Market Size by Region: 2016 Versus 2021 Versus 2027

2 Drug Eluting Implant Market Competition by Manufacturers

• 2.1 Global Drug Eluting Implant Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Drug Eluting Implant Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Drug Eluting Implant Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Drug Eluting Implant Manufacturing Sites, Area Served, Product Type
• 2.5 Drug Eluting Implant Market Competitive Situation and Trends
  • 2.5.1 Drug Eluting Implant Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Drug Eluting Implant Players Market Share by Revenue
  • 2.5.3 Global Drug Eluting Implant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Drug Eluting Implant Retrospective Market Scenario by Region

• 3.1 Global Drug Eluting Implant Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Drug Eluting Implant Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Drug Eluting Implant Market Facts & Figures by Country
  • 3.3.1 North America Drug Eluting Implant Sales by Country
  • 3.3.2 North America Drug Eluting Implant Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Drug Eluting Implant Market Facts & Figures by Country
  • 3.4.1 Europe Drug Eluting Implant Sales by Country
  • 3.4.2 Europe Drug Eluting Implant Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Drug Eluting Implant Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Drug Eluting Implant Sales by Region
  • 3.5.2 Asia Pacific Drug Eluting Implant Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Drug Eluting Implant Market Facts & Figures by Country
  • 3.6.1 Latin America Drug Eluting Implant Sales by Country
  • 3.6.2 Latin America Drug Eluting Implant Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa Drug Eluting Implant Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Drug Eluting Implant Sales by Country
  • 3.7.2 Middle East and Africa Drug Eluting Implant Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Drug Eluting Implant Historic Market Analysis by Type

• 4.1 Global Drug Eluting Implant Sales Market Share by Type (2016-2021)
• 4.2 Global Drug Eluting Implant Revenue Market Share by Type (2016-2021)
• 4.3 Global Drug Eluting Implant Price by Type (2016-2021)

5 Global Drug Eluting Implant Historic Market Analysis by Application

• 5.1 Global Drug Eluting Implant Sales Market Share by Application (2016-2021)
• 5.2 Global Drug Eluting Implant Revenue Market Share by Application (2016-2021)
• 5.3 Global Drug Eluting Implant Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Boston Scientific
  • 6.1.1 Boston Scientific Corporation Information
  • 6.1.2 Boston Scientific Description and Business Overview
  • 6.1.3 Boston Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Boston Scientific Drug Eluting Implant Product Portfolio
  • 6.1.5 Boston Scientific Recent Developments/Updates
• 6.2 Medtronic
  • 6.2.1 Medtronic Corporation Information
  • 6.2.2 Medtronic Description and Business Overview
  • 6.2.3 Medtronic Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Medtronic Drug Eluting Implant Product Portfolio
  • 6.2.5 Medtronic Recent Developments/Updates
• 6.3 Abbott
  • 6.3.1 Abbott Corporation Information
  • 6.3.2 Abbott Description and Business Overview
  • 6.3.3 Abbott Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Abbott Drug Eluting Implant Product Portfolio
  • 6.3.5 Abbott Recent Developments/Updates
• 6.4 Lepu Medical
  • 6.4.1 Lepu Medical Corporation Information
  • 6.4.2 Lepu Medical Description and Business Overview
  • 6.4.3 Lepu Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Lepu Medical Drug Eluting Implant Product Portfolio
  • 6.4.5 Lepu Medical Recent Developments/Updates
• 6.5 B. Braun Melsungen
  • 6.5.1 B. Braun Melsungen Corporation Information
  • 6.5.2 B. Braun Melsungen Description and Business Overview
  • 6.5.3 B. Braun Melsungen Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 B. Braun Melsungen Drug Eluting Implant Product Portfolio
  • 6.5.5 B. Braun Melsungen Recent Developments/Updates
• 6.6 MicroPort Scientific
  • 6.6.1 MicroPort Scientific Corporation Information
  • 6.6.2 MicroPort Scientific Description and Business Overview
  • 6.6.3 MicroPort Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 MicroPort Scientific Drug Eluting Implant Product Portfolio
  • 6.6.5 MicroPort Scientific Recent Developments/Updates
• 6.7 Cook Medical
  • 6.6.1 Cook Medical Corporation Information
  • 6.6.2 Cook Medical Description and Business Overview
  • 6.6.3 Cook Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Cook Medical Drug Eluting Implant Product Portfolio
  • 6.7.5 Cook Medical Recent Developments/Updates
• 6.8 Terumo
  • 6.8.1 Terumo Corporation Information
  • 6.8.2 Terumo Description and Business Overview
  • 6.8.3 Terumo Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Terumo Drug Eluting Implant Product Portfolio
  • 6.8.5 Terumo Recent Developments/Updates
• 6.9 Biosensors International
  • 6.9.1 Biosensors International Corporation Information
  • 6.9.2 Biosensors International Description and Business Overview
  • 6.9.3 Biosensors International Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Biosensors International Drug Eluting Implant Product Portfolio
  • 6.9.5 Biosensors International Recent Developments/Updates
• 6.10 Balton
  • 6.10.1 Balton Corporation Information
  • 6.10.2 Balton Description and Business Overview
  • 6.10.3 Balton Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Balton Drug Eluting Implant Product Portfolio
  • 6.10.5 Balton Recent Developments/Updates
• 6.11 AlviMedica Medical Technologies
  • 6.11.1 AlviMedica Medical Technologies Corporation Information
  • 6.11.2 AlviMedica Medical Technologies Drug Eluting Implant Description and Business Overview
  • 6.11.3 AlviMedica Medical Technologies Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 AlviMedica Medical Technologies Drug Eluting Implant Product Portfolio
  • 6.11.5 AlviMedica Medical Technologies Recent Developments/Updates
• 6.12 Biotronik
  • 6.12.1 Biotronik Corporation Information
  • 6.12.2 Biotronik Drug Eluting Implant Description and Business Overview
  • 6.12.3 Biotronik Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Biotronik Drug Eluting Implant Product Portfolio
  • 6.12.5 Biotronik Recent Developments/Updates
• 6.13 Shandong JW Medical
  • 6.13.1 Shandong JW Medical Corporation Information
  • 6.13.2 Shandong JW Medical Drug Eluting Implant Description and Business Overview
  • 6.13.3 Shandong JW Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Shandong JW Medical Drug Eluting Implant Product Portfolio
  • 6.13.5 Shandong JW Medical Recent Developments/Updates
• 6.14 Sino Medical
  • 6.14.1 Sino Medical Corporation Information
  • 6.14.2 Sino Medical Drug Eluting Implant Description and Business Overview
  • 6.14.3 Sino Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Sino Medical Drug Eluting Implant Product Portfolio
  • 6.14.5 Sino Medical Recent Developments/Updates
• 6.15 Beijing AMSINO
  • 6.15.1 Beijing AMSINO Corporation Information
  • 6.15.2 Beijing AMSINO Drug Eluting Implant Description and Business Overview
  • 6.15.3 Beijing AMSINO Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Beijing AMSINO Drug Eluting Implant Product Portfolio
  • 6.15.5 Beijing AMSINO Recent Developments/Updates

7 Drug Eluting Implant Manufacturing Cost Analysis

• 7.1 Drug Eluting Implant Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Drug Eluting Implant
• 7.4 Drug Eluting Implant Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Drug Eluting Implant Distributors List
• 8.3 Drug Eluting Implant Customers

9 Drug Eluting Implant Market Dynamics

• 9.1 Drug Eluting Implant Industry Trends
• 9.2 Drug Eluting Implant Growth Drivers
• 9.3 Drug Eluting Implant Market Challenges
• 9.4 Drug Eluting Implant Market Restraints

10 Global Market Forecast

• 10.1 Drug Eluting Implant Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Drug Eluting Implant by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Drug Eluting Implant by Type (2022-2027)
• 10.2 Drug Eluting Implant Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Drug Eluting Implant by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Drug Eluting Implant by Application (2022-2027)
• 10.3 Drug Eluting Implant Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Drug Eluting Implant by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Drug Eluting Implant by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List